Altamira Therapeutics Ltd. (CYTOF)
OTCMKTS · Delayed Price · Currency is USD
0.0651
0.00 (0.00%)
At close: Nov 28, 2025
Altamira Therapeutics Employees
Altamira Therapeutics had 11 employees as of December 31, 2024. The number of employees increased by 1 or 8.65% compared to the previous year.
Employees
11
Change (1Y)
1
Growth (1Y)
8.65%
Revenue / Employee
n/a
Profits / Employee
-$513,903
Market Cap
371.79K
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 11 | 1 | 8.65% |
| Dec 31, 2023 | 10 | -6 | -36.20% |
| Jan 1, 2023 | 16 | 2 | 12.41% |
| Dec 31, 2021 | 15 | 6 | 79.01% |
| Dec 31, 2020 | 8 | 0 | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| American Oncology Network | 1,914 |
| Glass House Brands | 374 |
| Silence Therapeutics | 116 |
| Elite Pharmaceuticals | 68 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 13 |
Altamira Therapeutics News
- 10 days ago - Altamira Therapeutics Announces Certification of Bentrio Nasal Spray under Medical Device Regulation - Accesswire
- 27 days ago - Altamira Therapeutics Announces Successful Nanoparticle-Based Delivery of DNA Molecules - Accesswire
- 3 months ago - Altamira Therapeutics Provides Business Update and First Half 2025 Financial Results - Accesswire
- 3 months ago - Altamira Therapeutics to Host First Half 2025 Financial Results and Business Update Call on August 29, 2025 - Accesswire
- 4 months ago - Altamira Therapeutics Announces Allowance of Japanese Patent Application Covering Intranasal Betahistine - Accesswire
- 6 months ago - Altamira Therapeutics Announces Collaboration on Circular RNA Delivery - GlobeNewsWire
- 7 months ago - Altamira Therapeutics Ltd. (CYTOF) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 7 months ago - Altamira Therapeutics Provides Business Update, Reports Full Year 2024 Financial Results - GlobeNewsWire